BIOMAT Database Logo BIOMAT Database Logo

Early detection of ovarian cancer: preliminary results of the Yale Early Detection Program. 1991

P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06510.

Eighty-four women at high risk for ovarian cancer by having first-degree relatives with epithelial ovarian cancer participated in a newly established, early ovarian cancer detection program at Yale University. Participants were to be evaluated with physical examinations and circulating tumor markers at entry and every six months thereafter. Endovaginal ultrasound and color Doppler flow studies were to be performed at three and nine months following entry into the program. In addition, women were encouraged to follow American Cancer Society guidelines for mammography. Stool was checked for occult blood. Endometrial sampling was offered to post-menopausal women. No participant has developed an ovarian cancer since entering the program. One woman has been diagnosed to have breast cancer. False-positive levels of circulating tumor markers (CA 125, 4/84 [4.8 percent]; lipid-associated sialic acid in plasma, 13/84 [15.5 percent]; NB/70K, 4/84 [4.8 percent]; and urinary gonadotropin fragment, 1/65 [1.5 percent]) were observed on entry into the program. Low resistive indices (less than 0.5) were documented in 8/91 (8.8 percent) ovaries studied by the color Doppler flow technique. One participant underwent a laparotomy based on a false-positive endovaginal ultrasound examination. Tests now being employed in community practice have a high likelihood of being associated with false-positive results. Therapeutic interventions based on isolated abnormal tumor markers or ultrasound studies obtained from women with family histories of ovarian cancer may lead to inappropriate surgery. It is necessary for cancer centers to develop expertise in ovarian cancer detection techniques to advise physicians in their geographic areas appropriately about the significance of the abnormal screening test.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D014463 Ultrasonography The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz. Echography,Echotomography,Echotomography, Computer,Sonography, Medical,Tomography, Ultrasonic,Ultrasonic Diagnosis,Ultrasonic Imaging,Ultrasonographic Imaging,Computer Echotomography,Diagnosis, Ultrasonic,Diagnostic Ultrasound,Ultrasonic Tomography,Ultrasound Imaging,Diagnoses, Ultrasonic,Diagnostic Ultrasounds,Imaging, Ultrasonic,Imaging, Ultrasonographic,Imaging, Ultrasound,Imagings, Ultrasonographic,Imagings, Ultrasound,Medical Sonography,Ultrasonic Diagnoses,Ultrasonographic Imagings,Ultrasound, Diagnostic,Ultrasounds, Diagnostic

Related Publications

P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Ovarian cancer early detection program.
June 1999, Oncology nursing forum,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP).
January 2002, Cancer treatment and research,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Social work role in an early ovarian cancer detection program.
January 1993, Social work in health care,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
[An early detection program for respiratory insufficiency in Duchenne's disease: the preliminary results].
January 1996, Archivos de bronconeumologia,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: Introduction.
October 1984, The American review of respiratory disease,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Detection of early ovarian cancer.
August 1990, Lancet (London, England),
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Early Detection of Ovarian Cancer.
December 2018, Hematology/oncology clinics of North America,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
[Early detection of ovarian cancer].
January 1978, Voprosy onkologii,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Early detection of ovarian cancer.
October 2020, European radiology,
P E Schwartz, and J T Chambers, and K J Taylor, and J Pellerito, and L Hammers, and L A Cole, and T L Yang-Feng, and P Smith, and S T Mayne, and R Makuch
Early detection of ovarian cancer.
January 1995, CA: a cancer journal for clinicians,
Copied contents to your clipboard!